Physician

Deepan Shailesh Dalal, MD, MPH

According to 2025 Medicare claims, Deepan Dalal, MD, MPH (NPI: 1962720441) practices rheumatology in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Providence, RI. This provider's primary affiliated billing organization is RI RHEUMATOLOGY LLC (NPI: 1194487603; TIN: 87-2055232) and primary practice location at 02910-4451. Dalal is affiliated with the Lifespan Health Alliance, LLC (ACO ID: A3336) and RIPC Population Management LLC (ACO ID: A5561), participating under the MSSP model.

Dalal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 363 traditional Medicare patients, billed 77,659 HCPCS/CPT codes, and received $804,038 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,292 prescription claims across 596 beneficiaries totaling $1,199,802 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 191 records totaling $29,215. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $14,321 to $804,038. Similarly, Part D prescription costs have moved sharply higher in recent years, from $71,770 to $1,199,802. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	69	155	$14,321
2016	142	444	$31,421
2017	173	521	$39,593
2018	160	455	$32,346
2019	208	600	$42,260
2020	213	563	$39,730
2021	217	583	$47,629
2022	238	13,525	$299,029
2023	334	46,833	$551,376
2024	363	77,659	$804,038

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	70	296	$71,770
2016	77	329	$93,286
2017	95	626	$126,194
2018	136	966	$311,638
2019	190	1,322	$301,443
2020	211	1,601	$549,383
2021	254	2,033	$748,327
2022	395	2,243	$824,122
2023	459	2,722	$1,182,005
2024	596	3,292	$1,199,802

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	59	59	$166
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	84	84	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	254	452	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	75	97	$66
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	68	770	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	68	1,904	$538,960
Enbrel	Etanercept	26	728	$191,194
Enbrel Mini	Etanercept	23	672	$177,350
Enbrel Sureclick	Etanercept	12	336	$99,652
Actemra Actpen	Tocilizumab	13	364	$60,479

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	191	$29,215	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Deepan Shailesh Dalal, MD, MPH?

Tedicare shows public-source Medicare data for Deepan Shailesh Dalal, MD, MPH (NPI 1962720441), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Deepan Shailesh Dalal, MD, MPH have ACO affiliation data?

Deepan Shailesh Dalal, MD, MPH is shown with ACO affiliation data for Lifespan Health Alliance, LLC (MSSP, ACO ID A3336) and RIPC Population Management LLC (MSSP, ACO ID A5561).

What billing organization is linked to Deepan Shailesh Dalal, MD, MPH?

Deepan Shailesh Dalal, MD, MPH is linked to RI RHEUMATOLOGY LLC (billing NPI 1194487603) in the available physician profile data.

Does Deepan Shailesh Dalal, MD, MPH have Open Payments data?

Deepan Shailesh Dalal, MD, MPH has 191 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.